Diseases, Conditions, Syndromes

FDA approves Rinvoq for treatment of atopic dermatitis

The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.


Q and A: What is pharmacogenomics?

DEAR MAYO CLINIC: I've been hearing a lot about lab tests that can look at my genetics to see how I metabolize medications. How does this work and why is it important for me to know how my body metabolizes medicine?

Radiology & Imaging

FDA: Stop using Eco-Med ultrasound gels, lotions

(HealthDay)—Health care providers and facilities should immediately stop using and discard all ultrasound gels and lotions manufactured by Eco-Med Pharmaceutical Inc. due to a risk for bacterial contamination, according ...


mRNA-1273 SARS-CoV-2 vaccine seems safe for adolescents

(HealthDay)—The results of an interim analysis suggest that two doses of the Moderna mRNA-1273 vaccine safely induce protective levels of antibodies to SARS-CoV-2 among adolescents, according to a study published online ...

page 1 from 23